US 12280140
Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
granted A61KA61K38/2013A61K40/11
Quick answer
US patent 12280140 (Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy) held by Iovance Biotherapeutics, Inc. expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Iovance Biotherapeutics, Inc.
- Grant date
- Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/2013, A61K40/11, A61K40/42, A61K9/0019